# Tenofovir, Emtricitabine and Efavirenz Late Switch to a Single Pill: Patients' Opinion Survey

> **NCT01322932** · — · COMPLETED · sponsor: **Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland** · enrollment: 95 (actual)

## Conditions studied

- HIV Infection

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01322932
- **Lead sponsor:** Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2011-10
- **Final completion:** 2012-02
- **Target enrollment:** 95 (ACTUAL)
- **Last updated:** 2015-12-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01322932

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01322932, "Tenofovir, Emtricitabine and Efavirenz Late Switch to a Single Pill: Patients' Opinion Survey". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT01322932. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*